Legacy Advisors’s Abiomed Inc ABMD Stock Holding History

Legacy Advisors’s Portfolio ABMD Stock Details ABMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-1,049	Closed	-$258K	–	253
2022 Q3	$258K	Buy	1,049 +235	+29%	+$63.5K	0.06%	186
2022 Q2	$201K	Buy	+814	New	+$220K	0.04%	207
2017 Q1	–	Sell	-2,600	Closed	-$292K	–	224
2016 Q4	$292K	Buy	+2,600	New	+$301K	0.4%	31

Other funds holding ABMD

TRSOTSOK

Teachers Retirement System of the State of Kentucky Frankfort, Kentucky $12.9B AUM 31.03% 1-Year Est. Return

BTI

Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

Rockefeller Capital Management New York $56.4B AUM 24.96% 1-Year Est. Return

IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return

Avion Wealth The Woodlands, Texas $484M AUM 15.17% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Legacy Advisors's ABMD Position: Q4 2022 in Review

Legacy Advisors sold out of Abiomed Inc (ABMD) in Q4 2022, closing a stake of 1,049 shares — an estimated $258K sold.

Legacy Advisors first reported a position in ABMD in Q4 2016 and held it in 3 quarters. The position peaked at $292K in Q4 2016. 8 funds tracked by Wall St. Rank hold ABMD as of Q4 2022.

Legacy Advisors reported no remaining Abiomed Inc position as of Q4 2022 after selling out during the quarter.
Legacy Advisors sold 1,049 Abiomed Inc shares in Q4 2022, an estimated $258K.
Legacy Advisors first reported a position in Abiomed Inc in Q4 2016 and held it in 3 quarters.
Legacy Advisors's Abiomed Inc position peaked at $292K in Q4 2016.
8 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2022.

Based on Legacy Advisors's 13F filing for Q4 2022, filed 1 Feb 2023.